COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab

INTRODUCTION: The SARS-CoV-2 pandemic necessitated better understanding of the impact of disease-modifying therapies on COVID-19 outcomes and vaccination. We report characteristics of COVID-19 cases and vaccination status in ofatumumab-treated relapsing multiple sclerosis (RMS) patients. METHODS: CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Cross, Anne H., Delgado, Silvia, Habek, Mario, Davydovskaya, Maria, Ward, Brian J., Cree, Bruce A. C., Totolyan, Natalia, Pingili, Ratnakar, Mancione, Linda, Hu, Xixi, Sullivan, Roseanne, Su, Wendy, Zielman, Ronald, Gupta, Ayan Das, Montalban, Xavier, Winthrop, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918079/
https://www.ncbi.nlm.nih.gov/pubmed/35284994
http://dx.doi.org/10.1007/s40120-022-00341-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918079/
https://www.ncbi.nlm.nih.gov/pubmed/35284994
http://dx.doi.org/10.1007/s40120-022-00341-z

Ejemplares similares